This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Drexel University, Inovio Pharmaceuticals, Inc., University of Pennsylvania. Active years: 2016.
Company Filing History:
1 out of 668 
1 out of 93 
1 out of 2,655 
Years Active: 2016
Title: J Joseph Kim: Innovator in Vaccine Development
Introduction
J Joseph Kim is a notable inventor based in Harleyville, PA (US). He has made significant contributions to the field of vaccine development, particularly in relation to Clostridium difficile. His work has the potential to impact public health positively.
Latest Patents
J Joseph Kim holds a patent for a Clostridium difficile DNA vaccine. This invention relates to compositions and methods for treating associated disease (CDAD) through the administration to a subject in need thereof at least one nucleic acid encoding at least a portion of at least one of toxin A and toxin B. This innovative approach aims to provide a new avenue for treatment and prevention.
Career Highlights
Throughout his career, J Joseph Kim has worked with several prominent organizations. He has been associated with the Philadelphia Health and Education Corporation and Inovio Pharmaceuticals, Inc. His experience in these companies has allowed him to develop and refine his expertise in vaccine technology.
Collaborations
J Joseph Kim has collaborated with notable professionals in his field, including Michele Kutzler and Scott Baliban. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
J Joseph Kim is a distinguished inventor whose work in vaccine development is paving the way for new treatments for Clostridium difficile infections. His contributions to the field are invaluable and demonstrate the importance of innovation in healthcare.